The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Franklin Genomic Advancements ETF HELX ETF Analysis
Morningstar’s Analysis HELX
Will HELX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar